posted
Just saw this on their website -- very interesting article!
Nutra Pharma Reports Final Results for ReceptoPharm's RPI-78M in Multiple Sclerosis Animal Model
"Nutra Pharma Corp., (OTCBB: NPHC) a biotechnology holding company that owns rights to intellectual property related to the development of drugs for HIV and Multiple Sclerosis has announced the completion of studies using RPI-78M in an animal model of Multiple Sclerosis (MS). RPI-78M is the lead drug candidate of Nutra Pharma's holding, ReceptoPharm, Inc. and is being studied in preclinical assays for its efficacy in treating MS." full release at http://www.nutrapharma.comPosts: 91 | Registered: Oct 2004
| IP: Logged |